Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Etoposide, Oxaliplatin and Capecitabine in Patients With Advanced HCC

NCT00351195 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT00351195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00351195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Etoposide, Oxaliplatin and Capecitabine in Patients With Advanced HCC
Lead sponsor
Rigshospitalet, Denmark
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2006
Completion date
April 30, 2007
Enrollment
39 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma